Eicosanoid imbalance in the NOD mouse is related to a dysregulation in soluble epoxide hydrolase and 15-PGDH expression

Annals of the New York Academy of Sciences

Volumn 1079, Issue , 2006, Pages 130-134

  Rodriguez, Michelle ^a   Clare Salzler, Michael ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

15 PGDH; Eicosanoids; Epoxide hydrolase; Inflammation; Lipoxin A4; Type 1 diabetes

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; CYCLOOXYGENASE 2; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; ICOSANOID; LEUKOTRIENE; LIPOXIN A; LIPOXYGENASE; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME REGULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PROTEIN EXPRESSION;

EID: 33845685815     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1375.019     Document Type: Conference Paper

References (8)

1. FITZPATRICK, F.A. 2004. Cyclooxygenase enzymes: regulation and function. Curr. Pharm. Des. 10: 577-588.
2. NASSAR, G.M. & K.F. BADR. 1995. Role of leukotrienes and lipoxygenases in glomerular injury. Miner. Electrolyte Metab. 21: 262-270.
3. CLISH, C.B., B.D. LEVY, et al. 2000. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. J. Biol. Chem. 275: 25372-25380.
4. NODE, K., Y. HUO, et al. 1999. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285: 1276-1279.
5. SPECTOR, A.A., X. FANG, et al. 2004. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog. Lipid Res. 43: 55-90.
6. SCHMELZER, K.R., L. KUBALA, et al. 2005. Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc. Natl. Acad. Sci. USA. 102: 9772-9777. Available at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?orig_db= PubMed&db=PubMed&cmd=Search&term= Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+ America%5BJour%5D+AND+102%5Bvolume%5D+AND+9772%5Bpage%5D+AND+2005%5Bpdat%5D+ AND+Schmelzer+K%5Bauthor%5D.
7. LITHERLAND, S., T. XIE, et al. 2000. Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. J. Clin. Invest. 104: 515-523.
8. LETY, M.A., J. COULAUD, et al. 1992. Enhanced metabolism of arachidonic acid by macrophages from nonobese diabetic (NOD) mice. Clin. Immunol. Immunopathol. 64: 188-196.